Company Profile

Kallo Inc. develops customized health care solutions. It offers a healthcare delivery program, focused on providing a healthcare solution that is customized to the requirements of each country, including effective infectious disease management and customized education and training programs. Its Kallo Integrated Delivery System (KIDS) product consists of three components: care platforms, digital technology and education & training. Care platforms include the care facility platforms - MobileCare and RuralCare, Dialysis care and brick and mortar hospitals as well as the emergency medical services care both land and air transportation. Digital technology includes the electronic medical records, picture archiving and communication system, eLearning system, eGovernance solutions as well as its Tele-health solution that supports the global and regional response centers for real time support of medical emergencies. It provides education and training for all aspects of healthcare management.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

22-08-31	Kallo Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
22-07-13	Kallo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-06-03	Kallo Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
22-06-02	Kallo Inc. Auditor Raises 'Going Concern' Doubt	CI
21-11-12	Kallo Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-08-23	Kallo Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
21-05-27	Kallo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	CI
21-01-14	Kallo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	CI
20-12-23	Kallo Inc. Receives Copies of the Contract Documents for National Healthcare Projects from the Ministry of Health and the Ministry of Finance of the State of Eritrea	CI
20-12-17	Kallo Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	CI
19-12-17	Kallo Inc. Enters into Joint Venture Corporation Agreement with Techno-Investment Module, Ltd and Vintage Ventures Limited	CI
18-04-16	Kallo Inc. Auditor Raises 'Going Concern' Doubt	CI
17-11-13	Kallo Inc. Auditor Raises 'Going Concern' Doubt	CI

22-08-31	REPORT AND IN MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. THE RISKS INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS	AQ
22-07-13	REPORT AND IN MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. THE RISKS INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS	AQ
22-06-03	KALLO INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ
21-11-12	REPORT AND IN MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. THE RISKS INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS	AQ
21-10-18	Kallo : Unregistered Sales of Equity Securities - Form 8-K	PU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KALLO INC	-.--%	-0.99%	-	-	6.36K
VEEVA SYSTEMS INC.	+2.48%	+4.61%	-29.75%	-4.07%	31.46B
PRO MEDICUS LIMITED	+0.62%	-8.64%	-40.32%	+195.94%	14.08B
SECTRA AB	-1.06%	-1.90%	-23.38%	+69.11%	5.65B
HEARTFLOW, INC.	-4.40%	-5.41%	-	-	2.35B
OMNICELL, INC.	+0.92%	+3.72%	+70.21%	-33.73%	2.13B
GENERATE BIOMEDICINES, INC.	-3.09%	-13.49%	-	-	1.8B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	+3.15%	+1.69%	-32.76%	-	1.08B
ARBUTUS BIOPHARMA CORPORATION	+3.18%	-7.88%	+51.28%	+110.44%	901M
RAYSEARCH LABORATORIES AB	-19.62%	-22.87%	-50.37%	+169.37%	795M
Average	-1.70%	-3.11%	-7.87%	+84.51%	6.69B
Weighted average by Cap.	+0.98%	-2.20%	-27.01%	+57.87%

Kallo Inc Stock Other OTC

Stocks

Advanced Medical Equipment & Technology

Latest news : Kallo Inc

Press Releases: Kallo Inc

Medical Software & Technology Services

Company Profile